Effect of Food on PC14586 in Healthy Volunteers and the PK of PC14586 in Healthy Japanese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 20, 2021

Primary Completion Date

June 9, 2022

Study Completion Date

June 9, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

PC14586

An oral dose of PC14586 will be used in Arms A and B (Part 1) and a different dose will be used for Arms C and D and the Japanese cohort (Part 2).

Trial Locations (1)

91206

Parexel Early Phase Clinical Unit - Los Angeles, Glendale

Sponsors
All Listed Sponsors
lead

PMV Pharmaceuticals, Inc

INDUSTRY